POET Technologies Inc (POET) Stock Analysis
Verdict: AVOID
A $796M cash cushion funds POET's AI photonics commercial ramp, but severe revenue lag and litigation risk keep valuation speculative.
Investment score: 36/100
Analysis as of
Is POET Technologies Inc stock worth reviewing? AI model thesis
POET Technologies possesses a fortress cash balance of $796.3M to commercialize its optical interposer technology, but with TTM revenue under $2M and a P/S ratio of 648x, the model sees the stock as an AVOID due to high valuation risk, securities fraud lawsuits, and extreme customer execution dependency.
7-factor investment score
- Valuation: 15/100 (weight 20%)
- Financial Health: 65/100 (weight 15%)
- Technical Momentum: 35/100 (weight 15%)
- Earnings Quality: 30/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
- Analyst Consensus: 50/100 (weight 10%)
- Risk-Adjusted Return: 30/100 (weight 15%)
POET Technologies Inc opportunities and risks
What speaks for POET
- $796.3M cash reserve provides over 10 years of operational runway to scale manufacturing.
What speaks against POET
- Ongoing securities class-action lawsuits and governance fallout following the April 2026 Marvell customer order cancellation.
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| POET | n/a | 648.1x | n/a | -68.0% | -4420.7% | -3.6% |
| CSIQ | n/a | 0.2x | 78.6x | 16.4% | -3.7% | -197.6% |
| QNC.V | n/a | 23417.6x | n/a | -2250.5% | -60279.6% | -1.1% |
| QSPW | n/a | 0.0x | n/a | 0.0% | 0.0% | -19112.5% |
| MMATQ | n/a | 0.0x | n/a | 58.9% | -4999.4% | -7550746.3% |
| Peer median | n/a | 0.1x | n/a | 8.2% | -2501.5% | -9655.1% |
Frequently asked questions about POET Technologies Inc (POET)
Is POET stock a good investment?
The cached TradeMates AI model rates POET Technologies Inc as AVOID with an investment score of 36/100. POET Technologies possesses a fortress cash balance of $796.3M to commercialize its optical interposer technology, but with TTM revenue under $2M and a P/S ratio of 648x, the model sees the stock as an AVOID due to high valuation risk, securities fraud lawsuits, and extreme customer execution dependency. This is algorithmic model output, not personal investment advice.
Is POET stock a buy?
The TradeMates model verdict for POET is AVOID with an investment score of 36/100. Treat this as a model signal to review, not a personal buy recommendation.